Animal Pharm's annual industry awards are designed to honor achievements within the animal health sector over the calendar year.
The last 12 months have been transformational for Ceva, as the company made large strides to achieving its top five ambitions.
Not only is Ceva stimulating growth internally with R&D in the areas of vaccines, genomics and livestock reproduction, it has also secured some significant acquisitions in 2016.The firm became one of the largest animal health companies in Brazil by acquiring two local businesses in November, while a month earlier it bought a range of products for pigs, cattle and companion animals from Merial. In fact, Ceva has been on the acquisition trail all year long.
In February, the company entered exclusive negotiations to merge its hatchery automation business with French firm iD Projects. A month later, Ceva broke into the Indian market after purchasing Indian business Polchem. Then, in June, it acquired Biovac Laboratories – another French business with expertise in autogenous vaccines, allergy treatments and reagents. The firm's expertise in markets such as veterinary vaccines, poultry and swine is helping it ride a wave of growth, while it also expands its horizons and becomes a truly global player.
Tuesday January 24 2017